Histology & IHCIHC Staining

VENTANA CLDN18 (43-14A) RxDx Assay

By Roche Diagnostics

Product TypeAssay Kit
TechnologyIHC Staining
Catalog / REF760-700
VENTANA CLDN18 (43-14A) RxDx Assay — Roche Diagnostics product image

Key takeaways

VENTANA CLDN18 (43-14A) RxDx Assay is a product in the Histology & IHC category, manufactured by Roche Diagnostics.

  • Platform: IHC Staining

Classification

Category
Histology & IHC
Product Type
Assay Kit
Technology
IHC Staining

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

  • The FDA-approved VENTANA CLDN18 (43-14A) RxDx Assay measures expression of both variants of the CLDN18 protein; however, CLDN18.2 is the dominant variant expressed in gastric cancers, making it the only candidate for identifying a previously undefined subset of patients.
    Roche DiagnosticsApplication AreaManufacturer Page2026-10-16
  • CLDN18.2 expression was assessed by IHC using the investigational VENTANA CLDN18 (43-14A) RxDx Assay in the SPOTLIGHT and GLOW clinical trials.
    Roche DiagnosticsTechnology PlatformManufacturer Page2026-10-16

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-16

Updated

2026-11-01

Disclaimer

availability varies

Explore more